Users Online Now:
Donate To GLP
Back to Forum
Back to Thread
REPLY TO THREAD
<<Advancing Bird Flu-H5N1...Now following MERS and Ebola approaching PANDEMICS>>>
Ms Sans Serif
In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article.
[quote:arkay:MV8xNzc2Mjk3XzM0NzAyOTg0XzMyMUFDMjM0] And just to highlight one very important reason why we might like to reconsider the contents of my previous post, we have this study done here in Australia on vaccination risks, and finding that risk increases could not be excluded for the small sampling used. Its no wonder that the average age of nurses in my local hospital is 55 years old and that the government cant attract nurses to train nor can they even attract nursing staff from overseas. Lousy pay, awfull working hours, overworked staff, the list goes on and now authorities would propose even more impediments. Perhaps its these people making all these proposals that have too much free time on their hands and need to be directed to more productive tasks. [i][b]Med J Aust. 2012 Nov 19;197(10):574-8. Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series. Crawford NW, Cheng A, Andrews N, Charles PG, Clothier HJ, Day B, Day T, Gates P, Macdonnell R, Roberts L, Rodriguez-Casero V, Wijeratne T, Kiers L. SourceRoyal Children's Hospital, Melbourne, VIC, Australia. email@example.com. Abstract OBJECTIVES: To determine the relative incidence (RI) of Guillain-Barré syndrome (GBS) in a single Australian state following pandemic (H1N1) 2009 influenza A immunisation (monovalent vaccine or seasonal trivalent influenza vaccine [TIV]) in 2009-2010. DESIGN, SETTING AND PARTICIPANTS: Active GBS surveillance (cases assessed by two neurologists according to the Brighton criteria) from 30 September 2009 to 30 September 2010, conducted at 10 hospitals in Victoria, Australia. MAIN OUTCOME MEASURES: The RI of GBS in the risk window of 0-42 days after vaccination. RESULTS: Sixty-six potential GBS cases were identified, with complete data on 50 confirmed cases. The Victorian annual incidence of GBS was 1.7 per 100 000 population. Three cases had received monovalent vaccine and one case had received seasonal TIV within 42 days of symptom onset. The RI of GBS following monovalent vaccination was 3.4 (95% CI, 0.8-15.0). For TIV, there was one case in the risk period (RI, 0.69; 95% CI, 0.08-5.64). CONCLUSIONS: This is the first published study reviewing GBS after a trivalent and/or monovalent influenza vaccine containing the pandemic (H1N1) 2009 strain, with only a small proportion of GBS cases occurring after influenza immunisation. H1N1-containing vaccines were not statistically associated with GBS, [u]but this study could not exclude smaller increases in the RI.[/u] Active surveillance of adverse events following immunisation is required to maintain public and health care professional confidence in mass vaccine implementation programs.[/b][/i] Link here... http://www.ncbi.nlm.nih.gov/pubmed/23163689 [/quote]
I previously engaged in several threads regarding the potentially devestating potential of H5N1.
Some readers who havent even attempted to gain any sort of education have downvoted my thread to the point that no-one got the chance to read and learn, on a topic that I have been closely monitoring for several years, ever since the World Health Organization announced their concerns for it to go pandemic.
Now the following link is showing its steady but relentless advance and in all probability its eventual final evolutionary mutation to become an airborne dissease that will readily spread throughout humanity with devistating effects.
link to hisz.rsoe.hu
Pictures (click to insert)
Big Round Smilies
Aliens and Space
Friendship & Love
Misc Small Smilies
View All Categories
Next Page >>
Disclaimer / Copyright Info
with questions or comments about this site.
"Godlike Productions" & "GLP" are registered trademarks of Zero Point Ltd. Godlike™
Website Design Copyright © 1999 - 2017 Godlikeproductions.com
Page generated in 0.005s (5 queries)